申请人:Selcia Limited
公开号:US20160220633A1
公开(公告)日:2016-08-04
Provided are compounds of Formula I:
and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
提供的是I式化合物及其药学上可接受的盐和酯。所提供的化合物、组合物和方法适用于治疗病毒感染,特别是丙型肝炎感染。